149 related articles for article (PubMed ID: 10504119)
1. First two cases of immune hemolytic anemia associated with ceftizoxime.
Shammo JM; Calhoun B; Mauer AM; Hoffman PC; Baron JM; Baron BW
Transfusion; 1999 Aug; 39(8):838-44. PubMed ID: 10504119
[TBL] [Abstract][Full Text] [Related]
2. Ceftizoxime-induced hemolysis secondary to combined drug adsorption and immune-complex mechanisms.
Calhoun BW; Junsanto T; Donoghue MT; Naureckas E; Baron JM; Baron BW
Transfusion; 2001 Jul; 41(7):893-7. PubMed ID: 11452157
[TBL] [Abstract][Full Text] [Related]
3. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests.
Arndt PA; Leger RM; Garratty G
Transfusion; 1999; 39(11-12):1239-46. PubMed ID: 10604252
[TBL] [Abstract][Full Text] [Related]
4. Ceftizoxime-induced hemolysis due to immune complexes: case report and determination of the epitope responsible for immune complex-mediated hemolysis.
Endoh T; Yagihashi A; Sasaki M; Watanabe N
Transfusion; 1999 Mar; 39(3):306-9. PubMed ID: 10204595
[TBL] [Abstract][Full Text] [Related]
5. 'Immune complex' mediated intravascular hemolysis due to IgM cephalosporin-dependent antibody.
Salama A; Göttsche B; Schleiffer T; Mueller-Eckhardt C
Transfusion; 1987; 27(6):460-3. PubMed ID: 3500531
[TBL] [Abstract][Full Text] [Related]
6. Cefotaxime-induced immune hemolytic anemia due to antibodies reacting in vitro by more than one mechanism.
Shulman IA; Arndt PA; McGehee W; Garratty G
Transfusion; 1990; 30(3):263-6. PubMed ID: 2316002
[TBL] [Abstract][Full Text] [Related]
7. Case report: Decreased hemoglobin and multiple organ failure caused by ceftizoxime-induced immune hemolytic anemia in a Chinese patient with malignant rectal cancer.
Lou C; Liu M; Ma T; Yang L; Long D; Li J; Lei H; Xiang D; Wang X; Li L; Cai X
Front Immunol; 2024; 15():1390082. PubMed ID: 38756782
[TBL] [Abstract][Full Text] [Related]
8. Cefotetan-induced immune hemolytic anemia.
Chenoweth CE; Judd WJ; Steiner EA; Kauffman CA
Clin Infect Dis; 1992 Nov; 15(5):863-5. PubMed ID: 1445986
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced immune hemolytic anemia: the last 30 years of changes.
Arndt PA
Immunohematology; 2014; 30(2):44-54. PubMed ID: 25247622
[TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
Franchini M; Piccoli PL; Gandini G; Giuffrida A; Bressan F; De Gironcoli M; Aprili G
Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871
[TBL] [Abstract][Full Text] [Related]
11. Immunologic cross-reactivity between penicillins and cephalosporins: a review.
Petz LD
J Infect Dis; 1978 May; 137 Suppl():S74-S79. PubMed ID: 77300
[TBL] [Abstract][Full Text] [Related]
12. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis.
Garratty G; Postoway N; Schwellenbach J; McMahill PC
Transfusion; 1991 Feb; 31(2):176-9. PubMed ID: 1825363
[TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone induced immune hemolytic anemia: detection of drug-dependent antibody by ex-vivo antigen in urine.
Kim S; Song KS; Kim HO; Lee HM
Yonsei Med J; 2002 Jun; 43(3):391-4. PubMed ID: 12089751
[TBL] [Abstract][Full Text] [Related]
14. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
Arndt PA; Leger RM; Garratty G
Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
[TBL] [Abstract][Full Text] [Related]
15. A case of immune hemolytic anemia induced by ceftizoxime and cefobactam (sulbactam/cefoperazone).
Baek EJ; Lee S; Kim S; Choi HK; Kim HO
Korean J Lab Med; 2009 Dec; 29(6):578-84. PubMed ID: 20046091
[TBL] [Abstract][Full Text] [Related]
16. Fatal immune haemolysis due to a degradation product of ceftriaxone.
Meyer O; Hackstein H; Hoppe B; Göbel FJ; Bein G; Salama A
Br J Haematol; 1999 Jun; 105(4):1084-5. PubMed ID: 10554824
[TBL] [Abstract][Full Text] [Related]
17. How we investigate drug-induced immune hemolytic anemia.
Leger RM; Arndt PA; Garratty G
Immunohematology; 2014; 30(2):85-94. PubMed ID: 25247618
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced immune hemolytic anemia.
Garratty G; Petz LD
Am J Med; 1975 Mar; 58(3):398-407. PubMed ID: 1090160
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced immune hemolytic anemia.
Garratty G
Hematology Am Soc Hematol Educ Program; 2009; ():73-9. PubMed ID: 20008184
[TBL] [Abstract][Full Text] [Related]
20. Severe immune-mediated hemolytic anemia secondary to treatment with cefotetan.
Gallagher NI; Schergen AK; Sokol-Anderson ML; Sheahan EJ; Chaplin H
Transfusion; 1992; 32(3):266-8. PubMed ID: 1557810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
